I am new to trading shares and Zelira was a tip from a girl friend, she is raving about the insomnia product coming to market soon, please excuse me firstly cause I know little about MEDICINE.
I decided to run the SWOT method over Zelira and particularly the Insomnia product. (Strength, weaknesses, opportunities and threats) to make an informed decision on just buying a few shares or getting more involved with some volume.
In my research I was pleased with what I found about the company overall for strengths, weaknesses and opportunity except for one news article relative to threats (competitors) in the market place.
TGA approval for over the counter Mela... this October, the question this places for me on the Zelira product gaining traction quickly and generating revenue is puzzling as a result, particularly when you will be able to buy a TGA approved product without prescription over the counter.
Does the product in the nine news clip work? (link attached to video/ news article below) Will the easy access to the product be a threat to Zelira's Insomnia product gaining traction on sales quickly?
Particularly the fact that you'll need a prescription to acquire the Zelira Insomnia product in Australia until TGA approves it? Am I right in saying that?
Any help on this would be very appreciated guys... As I have little understanding of insomnia or the related products available in the market but understand the potential here in the longterm..
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)